Analyst Reco. INVO Bioscience, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
0.76 ^USD	-2.56%		-10.60%	-43.70%

May. 15	INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	Top Premarket Decliners	MT

Roth Capital Downgrades INVO Bioscience to Neutral From Buy, Adjusts Price Target to $2 From $4	22-04-13	MT
Maxim Starts INVO Bioscience at Buy with $7 Price Target	22-01-19	MT
INVO BIOSCIENCE : Roth Capital Starts INVO Bioscience at Buy With $5.75 Price Target	20-12-29	MT

No results for this search